Kathleen A Page1,2, Shan Luo3,2, Xinhui Wang4, Ting Chow4, Jasmin Alves3,2, Thomas A Buchanan3,2, Anny H Xiang4. 1. Division of Endocrinology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA kpage@usc.edu. 2. Diabetes and Obesity Research Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA. 3. Division of Endocrinology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA. 4. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA.
Abstract
OBJECTIVE: Exposure in utero to maternal obesity or gestational diabetes mellitus (GDM) is linked to a high risk for obesity in offspring. Animal studies suggest that these exposures disrupt the development of the hypothalamus, a brain region that regulates body weight, predisposing offspring to develop obesity. This study tested the hypothesis in humans that in utero exposure to maternal obesity and/or GDM is associated with alterations in the hypothalamic response to glucose and the altered hypothalamic response would predict greater increases in child adiposity 1 year later. RESEARCH DESIGN AND METHODS: Participants were 91 children aged 7-11 years with and without in utero exposure to GDM. Maternal prepregnancy BMI and GDM exposures were determined from electronic medical records. Arterial spin labeling MRI was used to determine the child's hypothalamic blood flow response to oral glucose. Anthropometric measures were acquired in all children at their initial visit and again 1 year later in a subset of 44 children. RESULTS: Children exposed to GDM diagnosed at ≤26 weeks' gestation had increased hypothalamic blood flow (a marker of hypothalamic activation) in response to glucose when compared with unexposed children, and results remained after adjustments for child age, sex, BMI, and maternal prepregnancy BMI. Maternal prepregnancy BMI was positively associated with the child's hypothalamic response to glucose. Greater hypothalamic response to glucose predicted greater increases in child's BMI 1 year later. CONCLUSIONS: Increased glucose-linked hypothalamic activation during childhood represents a possible mechanism by which exposure to maternal metabolic disorders during fetal development increases future risk for obesity.
OBJECTIVE: Exposure in utero to maternal obesity or gestational diabetes mellitus (GDM) is linked to a high risk for obesity in offspring. Animal studies suggest that these exposures disrupt the development of the hypothalamus, a brain region that regulates body weight, predisposing offspring to develop obesity. This study tested the hypothesis in humans that in utero exposure to maternal obesity and/or GDM is associated with alterations in the hypothalamic response to glucose and the altered hypothalamic response would predict greater increases in child adiposity 1 year later. RESEARCH DESIGN AND METHODS: Participants were 91 children aged 7-11 years with and without in utero exposure to GDM. Maternal prepregnancy BMI and GDM exposures were determined from electronic medical records. Arterial spin labeling MRI was used to determine the child's hypothalamic blood flow response to oral glucose. Anthropometric measures were acquired in all children at their initial visit and again 1 year later in a subset of 44 children. RESULTS:Children exposed to GDM diagnosed at ≤26 weeks' gestation had increased hypothalamic blood flow (a marker of hypothalamic activation) in response to glucose when compared with unexposed children, and results remained after adjustments for child age, sex, BMI, and maternal prepregnancy BMI. Maternal prepregnancy BMI was positively associated with the child's hypothalamic response to glucose. Greater hypothalamic response to glucose predicted greater increases in child's BMI 1 year later. CONCLUSIONS: Increased glucose-linked hypothalamic activation during childhood represents a possible mechanism by which exposure to maternal metabolic disorders during fetal development increases future risk for obesity.
Authors: Solrun Vidarsdottir; Paul A M Smeets; Diane L Eichelsheim; Matthias J P van Osch; Max A Viergever; Johannes A Romijn; Jeroen van der Grond; Hanno Pijl Journal: Diabetes Date: 2007-08-01 Impact factor: 9.461
Authors: Manus J Donahue; Hanzhang Lu; Craig K Jones; Richard A E Edden; James J Pekar; Peter C M van Zijl Journal: Magn Reson Med Date: 2006-12 Impact factor: 4.668
Authors: Shan Luo; A James Melrose; Hilary Dorton; Jasmin Alves; John R Monterosso; Kathleen A Page Journal: Appetite Date: 2017-05-25 Impact factor: 3.868
Authors: Shan Luo; Brendan C Angelo; Ting Chow; John R Monterosso; Paul M Thompson; Anny H Xiang; Kathleen A Page Journal: Diabetes Care Date: 2021-04-07 Impact factor: 19.112
Authors: Anny H Xiang; Kathleen A Page; Jasmin M Alves; Brendan C Angelo; Jennifer Zink; Ting Chow; Alexandra G Yunker; Kristi Clark; Shan Luo; Britni Ryan Belcher; Megan M Herting; Christina M Dieli-Conwright Journal: Int J Obes (Lond) Date: 2021-03-17 Impact factor: 5.095